ATHE logo

ATHE
Alterity Therapeutics Ltd - ADR

8,841
Mkt Cap
$67.61M
Volume
4,575.00
52W High
$7.00
52W Low
$2.66
PE Ratio
-6.44
ATHE Fundamentals
Price
$3.85
Prev Close
$3.73
Open
$3.65
50D MA
$3.47
Beta
0.82
Avg. Volume
12,578.80
EPS (Annual)
-$0.7383
P/B
1.87
Rev/Employee
$0.00
$17.04
Loading...
Loading...
News
all
press releases
News Placeholder
Alterity Therapeutics Gains FDA Backing For Phase 3 MSA Trial
(RTTNews) - Alterity Therapeutics (ATHE, ATH.AX) announced that it has received positive regulatory feedback following a Type C Meeting with the U.S. Food and Drug Administration (FDA) regarding its planned Phase 3 development program for ATH434 in Multiple System Atrophy (MSA...
Nasdaq News: Markets·18d ago
News Placeholder
Alterity Therapeutics Announces Appointment Of Daniel Claassen As Chief Medical Advisor
(RTTNews) - Alterity Therapeutics Limited (ATHE), Wednesday announced the appointment of Daniel Claassen as Chief Medical Advisor, effective March 2026...
Nasdaq News: Markets·1mo ago
News Placeholder
Alterity Therapeutics Stock Doubles Premarket On Positive MSA Trial Results: Retail Excitement Soars
A 50mg dose of its ATH434 showed 8% reduction in clinical progression of early-stage multiple system atrophy vs. placebo.
Stocktwits·1y ago
<
...
1
>

Latest ATHE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.